Emerging Healthcare Advances Toward Sealing ThromboVision Deal

Emerging Healthcare Solutions, Inc. (Pinksheets:EHSI) announced today that management has formally delivered an actionable Term Sheet to ThromboVision for review and that follow up communications have been very favorable. The Term Sheet review is a major positive step that is necessary to pursue final terms under EHSI’s recent option agreement with ThromboVision, a company that has licensed the patent on the revolutionary new T-Guide® Platelet Function Analyzer, which is currently going through regulatory clearance review.

The T-Guide® is a brilliant development of new technology that does not require direct handling of blood, provides an economical testing means and should enable doctors to directly measure platelet status as easily as measuring cholesterol. The T-Guide® analyzer is a desktop instrument that uses a disposable test kit. The unit is designed so it can be located at doctor’s offices and could become a front line technology that could help prevent heart attacks, strokes and stent occlusions by directly analyzing a patient’s platelet status at the physician’s office. In the US, physicians incur 80 million cardiovascular visits each year, with over 30 million of these patients utilizing Aspirin or Plavix® platelet therapy.

The emerging healthcare industry is expected to continue strong expansion, regardless of what will eventually result in Washington, which could be beneficial to many cutting-edge companies such as Enzo Biochem (NYSE: ENZ), National Dentex (NASDAQ: NADX), Inverness Medical Innovations. (NYSE: IMA) and Radnet Inc. (NASDAQ: RDNT).

About Emerging Healthcare Solutions, Inc.

Emerging Healthcare Solutions, Inc. is a company dedicated to providing guidance to participants in the healthcare industry. Our primary goal is to give you a roadmap showing how to realize enormous profits from the changes occurring right now in the healthcare industry. Our common stock is traded under the symbol EHSI.

For more information, visit http://www.emerginghealthcaresolutionsinc.com.

Safe Harbor Statement under the Private Securities Litigation Reform Act of 1995: This news release contains forward-looking information within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended, including statements that include the words "believes," "expects," "anticipate" or similar expressions. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause the actual results, performance or achievements of the company to differ materially from those expressed or implied by such forward-looking statements. In addition, description of anyone's past success, either financial or strategic, is no guarantee of future success. This news release speaks as of the date first set forth above and the company assumes no responsibility to update the information included herein for events occurring after the date hereof.